Multidrug-resistant bacteria isolated from intensive-care-unit patient samples

Brazilian Journal of Infectious Diseases

Volumn 13, Issue 2, 2009, Pages 118-122

  Japoni, Aziz ^a   Vazin, Afsaneh ^b   Hamedi, Mahdi ^b   Davarpanah, Mohammad Ali ^c   Alborzi, Abdolvahab ^a   Rafaatpour, Noraladin ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Intensive care unit; Minimum inhibitory concentration; Multidrug resistant bacteria

Indexed keywords

AMPICILLIN; CEFAZOLIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; IMIPENEM; MEROPENEM; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; BLOOD SAMPLING; CEREBROSPINAL FLUID; COAGULASE NEGATIVE STAPHYLOCOCCUS; DRUG EFFICACY; ESCHERICHIA COLI; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INFECTION CONTROL; INFECTION RISK; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANT BACTERIUM; NONHUMAN; PEDIATRIC WARD; SURGICAL WARD; URINALYSIS;

ADULT; CHILD, PRESCHOOL; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; YOUNG ADULT;

EID: 76649093315     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702009000200009     Document Type: Article

References (25)

1. Singh A., Sen. M.R., Anupurba S., et al. Antibiotic sensitivity pattern of the bacteria isolated from nosocomial infections in ICU. J Commun Dis 2002;34:257-63.
2. Fridkin S.K. Increasing prevalence of antimicrobial resistance in intensive care units. Crit Care Med 2000;29(Suppl.4):64-8.
3. Wroblewska M.M., Swoboda-Kopec E., Rokosz A., et al. Epidemiology of clinical isolates of Candida albicans and their susceptibility to triazoles. Int J Antimicrob Agents 2002;20:472-5.
4. Namias N., Samiian L., Nino D., et al. Incidence and susceptibility of pathogenic bacteria vary between intensive care units within a single hospital: implications for empiric antibiotic strategies. J Trauma 2000;49:638-45.
5. Geffers C., Zuschneid I., Sohr D., et al. Microbiological isolates associated with nosocomial infections in intensive care units: data of 274 intensive care units participating in the German Nosocomial Infections Surveillance System (KISS). Anasthesiol Intensivmed Notfallme Schmertzther 2004;39:15-9.
6. Hsueh P.R., Liu Y.C., Yang D., et al. Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan. Microb Drug Resist 2001;7:373-82.
7. Rahbar M., Gra-Agaji R., Hashemi S. Nosocomial blood stream infections in Imam Khomeini Hospital, Urmia, Islamic Republic of Iran, 1999-2001. East Mediterr Health J 2005;11:478-84.
8. Cockerill F.R. 3rd., Reed G.S., Hughes J.G., et al. Clinical comparison of BACTEC 9240 plus aerobic/F resin bottles and the isolator aerobic culture system for detection of bloodstream infections. J Clin Microbiol 1997;35:1469-72.
9. Kumar Y., Qunibi M., Neal T.J., et al. Time to positivity of neonatal blood cultures. Arch Dis Child Fetal Neonatal Ed 2001;85:182-6.
10. Christiansen K.J., Turnidge J.D., Bell J.M., et al. Australian Group on Antimicrobial Resistance. Prevalence of antimicrobial resistance in Enterococcus isolates in Australia, 2005: report from the Australian Group on Antimicrobial Resistance. Commun Dis Intell 2007;31:392-7.
11. Levine D.P. Vancomycin: a history. Clin Infect Dis 2006;42Suppl1: 5-12.
12. Fridkin S.K., Gaynes R.P. Antimicrobial resistance in intensive care units. Clin Chest Med 1999;20:303-16.
13. Johnson A.P., Henwood C., Mushtaq S., et al. Susceptibility of Gram-positive bacteria from ICU patients in UK hospitals to antimicrobial agents. J Hosp Infect 2003;54:179-87.
14. Weber D.J., Rutala W.A. Use of germicides in the home and the healthcare setting: is there a relationship between germicide use and antibiotic resistance? Infect Control Hosp Epidemiol 2006;27:1107-19.
15. McDonnell G., Russell A.D. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev 1999;12:147-79.
16. Sheldon A.T. Antiseptic "resistance": real or perceived threat? Clin Infect Dis 2005;40:1650-6.
17. Hanberger H., Garcia-Rodriguez J.A., Gobernado M., et al. Antibiotic susceptibility among aerobic Gram-negative bacilli in intensive care units in 5 European countries. 2007.
18. Karlowsky J.A., Draghi D.C., Jones M.E., et al. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001.Antimicrob Agents Chemother 2003;47:1681- 8.
19. Wroblewska M.M., Rudnicka J., Marchel H., et al. Multidrug-resistant bacteria isolated from patients hospitalized in Intensive Care Units Int. J Antimicrob Agents 2006;27:285-9.
20. Bantar C., Alcazar G., Franco D., et al. Impact of antibiotic treatment on bacterial resistance rates from patients with hospital-acquired infection. J Chemother 2007;19:673-6.
21. Japoni A., Alborzi A., Kalani M., et al. Susceptibility patterns and cross-resistance of antibiotics against Pseudomonas aeruginosa isolated from burn patients in the South of Iran. Burns 2006;32:343-7.
22. Rapoport. J., Teres. D., Steingrub. J., et al. Patient characteristics and ICU organizational factors that influence frequency of pulmonary artery catheterization. JAMA 2000;283:2559-67.
23. Tabei S.Z., Heydari S.T., Mehrabani D., et al. Current substance use in patients with gastric cancer in Southern Iran. J Cancer Res Ther 2006;2:182-5.
24. Hashemi-Bahremani M., Parwaresch M.R., Tabrizchi H., et al. Lymphomas in Iran. Arch Iran Med 2007;10:343-8.
25. Montazeri A. Road-traffic-related mortality in Iran: a descriptive study. Public Health 2004;118:110-3.